MedPath

Electrophysiologic Changes in Blacks Treated With CBT for Insomnia

Not Applicable
Completed
Conditions
Insomnia
Registration Number
NCT02741336
Lead Sponsor
State University of New York - Downstate Medical Center
Brief Summary

Insomnia is a highly prevalent, often debilitating, and economically burdensome condition. Reviews of the literature indicate that there are ethnic differences in sleep behavior, with African Americans objectively and subjectively reporting more disordered sleep than Caucasian Americans.Chronic insomnia can have a significant impact on mental and physical health outcomes and has been associated with impaired cognitive performance, particularly, in areas of speed, attention, working memory, and executive function. In order to understand the brain mechanisms in sleep disorder both during resting state as well as during cognitive processing, the investigators will assess resting state EEG (during eyes-closed and eyes-open conditions) as well as ERP tasks for assessing decision-making and reward processing. The primary objective of the study is to evaluate the effect of a tailored, telephone-delivered cognitive behavioral intervention, versus a self- monitoring control condition, on symptoms of insomnia and its neurodynamic correlates.

Hypotheses: Among Blacks subjectively reporting symptoms of insomnia, those randomized to the tailored, telephone-delivered CBT-I, compared with those randomized to the self-monitoring control group, will have: Hyp. 1: Greater reduction in symptoms of insomnia as measured by the Pittsburgh Sleep Quality Index. Hyp. 2: Greater neurophysiologic improvement (ERP, ERO) in the intervention condition in response to laboratory paradigms Hyp 3: Greater improvement in psychosocial functioning including reduction in depression and increase in quality of life.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
10
Inclusion Criteria
  • A positive endorsement of insomnia items on the Sleep Disorders Questionnaire
  • Self- reported race/ethnicity as black (men and women)
  • Ages 30 to 50 years
  • Accessible by telephone
  • No plans to move away from the region within the year following enrollment
  • Consent to participate.
Exclusion Criteria
  • Documented co-existing sleep apnea
  • Self-reported use of sleep medication
  • Impaired cognitive or functional ability precluding meaningful participation
  • Stated intention to move within the same year of enrollment.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Sleep Diary2 months after enrollment
Secondary Outcome Measures
NameTimeMethod
QEEG tests of cognition2 months

Trial Locations

Locations (1)

SUNY Downstate Medical Center

🇺🇸

Brooklyn, New York, United States

SUNY Downstate Medical Center
🇺🇸Brooklyn, New York, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.